Overview

BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II study for safety and efficacy of BEB (Bendamustine, Etoposide, Busulfan) conditioning regimen for ASCT in non-Hodgkin's lymphoma
Phase:
Phase 2
Details
Lead Sponsor:
Pusan National University Hospital
Treatments:
Bendamustine Hydrochloride
Busulfan
Etoposide
Etoposide phosphate